Eptinezumab-jjmr Injection, for Intravenous Use HCPCS

Eptinezumab-jjmr Injection, for Intravenous Use HCPCS jjmr site Initial and renewal requests for the medication listed in this policy are subject to site of care management jjmr site For additional information, we encourage you to visit our corporate site com and connect with us on Twitter at @Lundbeck and via

jjmr site site Other side effects not listed may also occur in some patients If you notice any other effects, check with your healthcare professional

jjmrsite 11 An official website of the State of North Carolina An official website of NC How you know State Government websites value user privacy To Most common adverse events included injection site pain, nausea, dizziness, injection site Eptinezumab-jjmr was approved in February 21, 2020